亚临床慢性肾脏病改变实验性急性肾损伤的诊断
该研究在大鼠中诱导不伴血清肌酐升高的亚临床慢性肾脏病(CKD),再给予亚肾毒性剂量顺铂诱发急性肾损伤(AKI),发现亚临床CKD以相反方式改变功能与损伤生物标志物谱:功能标志物更敏感,而损伤标志物的诊断阈值和升高幅度降低且延迟。
要点
- 亚临床CKD时尿KIM-1、细胞色素C、MCP-1、簇集素、IL-18升高而血肌酐不升高。
- 腺嘌呤诱导亚临床CKD后AKI时血肌酐升高更快,尿KIM-1、簇集素、MCP-1升高延迟且幅度降低。
- 已知存在CKD时AKI生物标志物阈值可能需要降低或延迟采样。
核心结论
- 亚临床CKD以相反方式改变AKI的功能和损伤生物标志物谱:功能标志物更敏感,损伤标志物诊断阈值和升高幅度降低且延迟。
研究设计与样本
- 大鼠研究:用腺嘌呤或马兜铃酸诱导不伴血清肌酐升高的亚临床CKD,恢复三至六周后以亚肾毒性剂量顺铂诱导AKI。
主要发现
- 亚临床CKD诱导期间尿KIM-1、细胞色素C、MCP-1、簇集素、IL-18升高,而血清肌酐不升高。
- 腺嘌呤诱导亚临床CKD后AKI时血清肌酐升高更快,尿KIM-1、簇集素、MCP-1升高延迟且降低。
- 血清肌酐和生物标志物排泄增加与外髓外条纹弥漫性小管间质损伤及超过50%皮质损伤相关。
- 马兜铃酸诱导亚临床CKD后AKI时,第21天血清肌酐及尿KIM-1、簇集素、MCP-1、细胞色素C、IL-18浓度和排泄高于第42天,且与皮质损伤程度呈负相关。
临床怎么用
- 在已知存在CKD时,AKI损伤生物标志物的阈值可能需要降低或采样时间延迟。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extensive structural damage within the kidney must be present before serum creatinine increases. However, a subclinical phase of chronic kidney disease (CKD) usually goes undetected. Here we tested whether experimental subclinical CKD would modify functional and damage biomarker profiles of acute kidney injury (AKI). Subclinical CKD was induced in rats by adenine or aristolochic acid models but without increasing serum creatinine. After prolonged recovery (three to six weeks), AKI was induced with a subnephrotoxic dose of cisplatin. Urinary levels of kidney injury molecule-1 (KIM-1), cytochrome C, monocyte chemotactic protein-1 (MCP-1), clusterin, and interleukin-18 increased during CKD induction, without an increase in serum creatinine. After AKI in adenine-induced CKD, serum creatinine increased more rapidly, while increased urinary KIM-1, clusterin, and MCP-1 were delayed and reduced. Increased serum creatinine and biomarker excretion were associated with diffuse tubulointerstitial injury in the outer stripe of outer medulla coupled with over 50% cortical damage. Following AKI in aristolochic acid-induced CKD, increased serum creatinine, urinary KIM-1, clusterin, MCP-1, cytochrome C, and interleukin-18 concentrations and excretion were greater at day 21 than day 42 and inversely correlated with cortical injury. Subclinical CKD modified functional and damage biomarker profiles in diametrically opposite ways. Functional biomarker profiles were more sensitive, while damage biomarker diagnostic thresholds and increases were diminished and delayed. Damage biomarker concentrations and excretion were inversely linked to the extent of prior cortical damage. Thus, thresholds for AKI biomarkers may need to be lower or sampling delayed in the known presence of CKD.
引用
- Succar L, Pianta TJ, Davidson T, et al. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury. Kidney Int. 2017. PMID: 28476556. doi:10.1016/j.kint.2017.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。